JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH DOI: 10.1186/s13046-022-02528-6（2022）

UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.

一键分享

---